Resources

Previous research suggests that interpersonal relationships moderate treatment outcomes for opioid use disorder based on the nature and quality of the relationship.

To develop a better understanding of the context of drug use, we interviewed safer supply program participants in Ottawa, Canada.

This study utilized qualitative interviews to explore opioid withdrawal experiences and consequences among people who use opioids (PWUO) in Los Angeles County, USA.

This study investigates the effectiveness of a short video targeting pharmacists that addresses implementation barriers for take-home naloxone (THN).

Point-of-care drug checking identifies components of a drug sample and delivers results consumers.

To better identify individuals at risk and inform patients and clinicians about xylazine risk factors.

This study explores treatment experiences of people who use illicit stimulants (PWUS) to identify gaps and perceptions of prospective pharmaceutical stimulant substitution treatments (SST).

This study is the first one which compares patients' self-assessment of the risk of future opioid overdose with the hetero-assessment provided by healthcare professionals in a population of individ

We examined prevalence and sociodemographic correlates of past year presumed xylazine effects and association with overdose and wound-related outcomes.

We describe methadone and BUP/NX titration patterns and their associations with treatment outcomes among individuals with a prescription-type opioid use disorder (OUD).

Little is known about demand-side issues, such as reasons for use and pathways to opioid use.

We performed a national survey of people who use drugs to evaluate common drug use preparation, harm reduction practices, and experiences with injection site infections.

Community agencies and the City of Toronto opened COVID-19 isolation and recovery sites (CIRS) in March 2020.

Examine differences in neighborhood characteristics and services between overdose hotspot and non-hotspot neighborhoods and identify neighborhood-level population factors associated with increased

One form of safe supply enlists clinicians to prescribe opioids so that people have access to drugs of known composition and strength.

Transgender and gender diverse (TGD) people who use drugs report barriers to accessing substance use treatment, including provider mistreatment.